Examining Sustained Disability Signals With Vidofludimus Calcium in Progressive MS: Robert J. Fox, MD

05 Nov 2026 0 comments

The staff neurologist at the Mellen Center for Multiple Sclerosis at Cleveland Clinic discussed open-label extension data from the phase 2 CALLIPER trial of vidofludimus calcium in progressive multiple sclerosis. [WATCH TIME: 6 minutes]

Source: NeurologyLive Published 04 Nov 2026 Imported 04 Nov 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment